110P Outcomes of CUPem: A prospective phase II multicentre clinical trial of pembrolizumab in patients with pre-treated cancer of unknown primary
- Resource Type
- Abstract
- Source
- In
Immuno-Oncology and Technology December 2023 20 Supplement - Subject
- Language
- ISSN
- 2590-0188